ImmunityBio, Inc.（IBRX）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 ImmunityBio, Inc.（IBRX）报告了 71 笔 Form 4 交易（最近一笔 2026-10-06）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-06 | Simon Barry J. | 董事 | 卖出 | 25,000 | $268,760 |
| 2026-10-06 | Cohen Cheryl | 董事 | 买入 | 55,979 | $166,817 |
| 2026-10-06 | Cohen Cheryl | 董事 | 卖出 | 81,056 | $851,088 |
| 2026-07-06 | Cohen Cheryl | 董事 | 买入 | 55,979 | $166,817 |
| 2026-07-06 | Selecky Christobel | 董事 | 买入 | 35,064 | $104,491 |
| 2026-07-06 | Cohen Cheryl | 董事 | 卖出 | 131,210 | $1.2M |
| 2026-07-06 | Selecky Christobel | 董事 | 买入 | 124,414 | $371,998 |
| 2026-07-06 | Selecky Christobel | 董事 | 卖出 | 159,478 | $1.4M |
| 2026-07-01 | Selecky Christobel | 董事 | 买入 | 700 | $2,086 |
| 2026-07-01 | Selecky Christobel | 董事 | 买入 | 33,549 | $100,312 |
| 2026-07-01 | Selecky Christobel | 董事 | 买入 | 30,000 | $85,200 |
| 2026-07-01 | Selecky Christobel | 董事 | 卖出 | 95,722 | $862,216 |
| 2026-07-01 | Selecky Christobel | 董事 | 买入 | 32,173 | $95,876 |
| 2026-07-01 | Selecky Christobel | 董事 | 买入 | 300 | $897 |
| 2026-07-01 | Selecky Christobel | 董事 | 卖出 | 1,000 | $9,000 |
| 2026-06-26 | Simon Barry J. | 董事 | 卖出 | 25,000 | $197,000 |
| 2026-06-05 | Simon Barry J. | 董事 | 卖出 | 23,033 | $165,377 |
| 2026-04-02 | SOON-SHIONG PATRICK | Founder, Executive Chairman, Global Chief Scientific and Medical Officer | 买入 | 4.6M | $25.0M |
| 2026-04-02 | CALIFORNIA CAPITAL EQUITY, LLC | 10% 以上股东 | 买入 | 4.6M | $25.0M |
| 2026-04-02 | MP 13 Ventures, LLC | 10% 以上股东 | 买入 | 4.6M | $25.0M |
| 2026-04-02 | Cambridge Equities, LP | 10% 以上股东 | 买入 | 4.6M | $25.0M |
| 2026-04-02 | Nant Capital, LLC | 10% 以上股东 | 买入 | 4.6M | $25.0M |
| 2026-02-26 | Simon Barry J. | 董事 | 卖出 | 75,000 | $900,750 |
| 2026-02-24 | Sachs David C. | Chief Financial Officer | 卖出 | 20,682 | $179,933 |
| 2026-02-24 | Sachs David C. | Chief Financial Officer | 买入 | 40,650 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-06